Target intelligence / Profile preview

Lethal giant larvae protein homolog 2 (LLGL2)

Target
LLGL2
Molecular classification
Other (Cell polarity scaffold protein; Scribble polarity complex component)
01

Overview

Lethal giant larvae protein homolog 2 (LLGL2) is a highly conserved, non-enzymatic scaffolding protein that functions primarily in the regulation of apical-basal cell polarity, organization of cell junctions, and control of cell proliferation in epithelial tissues. LLGL2 is a core component of the Scribble polarity complex, along with Scribble (SCRIB) and Discs large (DLG), which antagonizes other polarity modules (such as Par and Crumbs complexes) to establish and maintain epithelial organization and tissue architecture. Structurally, LLGL2 contains a double β-propeller domain, and its association with the plasma membrane is regulated by phosphorylation via atypical protein kinase C (aPKC); this phosphorylation serves as a switch controlling its membrane localization and function[1][2][5]. Functionally, LLGL2 acts as a dynamic scaffold, regulating protein-protein interactions necessary for adherens and tight junction formation and maintenance, as well as maintaining epithelial barrier function and branching morphogenesis, such as in placental development[7]. As a tumor suppressor, the loss or dysfunction of LLGL2 is associated with disruption of cell polarity, increased ectopic proliferation, and promotion of tumorigenesis in various contexts[2][3][4]. Currently, LLGL2 is not a direct therapeutic target or known drug receptor, but its biological role as a tumor suppressor and regulator of epithelial integrity implicates it in diseases such as cancer and developmental defects when mutated or dysregulated[2][3][4][7].

Other names
HGLHugl-2LGL2Human giant larvae homolog 2Lethal(2) giant larvae protein homolog 2Scribble cell polarity complex component 2
02

Biological functions

Cell polarityCell proliferationCell junction formation and maintenanceTumor suppressionRegulation of epithelial integrityAsymmetric cell division
03

Disease associations

Cancer (tumor suppression; loss linked to tumorigenesis)Other (deficiencies linked to polarity and morphogenesis defects)
04

Safety considerations

Disruption may cause loss of cell polarity, increased proliferation, and neoplasia (tumor formation)

Beyond the preview

Go deeper on Lethal giant larvae protein homolog 2 (LLGL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lethal giant larvae protein homolog 2 (LLGL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call